Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 660 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Andrew Mcgarry, Shane Rosanbalm, Mika Leinonen,Warren Olanow, Dennis To,Adam Bell, Daniel Lee, Jamie Chang, Jordan Dubow, Rohit Dhall, Daniel Burdick, Sotirios Parashos,
LANCET NEUROLOGYno. 1 (2024): 37-45
Cited1Views0WOSBibtex
1
0
The 201 Trial in Untreated Parkinson’s Disease (P9-3.011)
Milton Werner,C Warren Olanow,Andrew McGarry, Christopher Meyer, Emaryn Mancino, Carl Klint, Jacqueline Pellecchia
Neurology（2024）
Cited0Views0Bibtex
0
0
A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease
Milton H. Werner,C. Warren Olanow,Andrew McGarry, Christopher Meyer, Sydney Kruger, Carl Klint, Jacqueline Pellecchia, Shannon Walaker,Larry Ereshefsky, Lawrence Blob,Howard Hassman, Carlos Rodriguez,
JOURNAL OF PARKINSONS DISEASEno. 2 (2024): 325-334
Cited0Views0WOSBibtex
0
0
Analysis of the therapeutic potential of IkT-148009 in Parkinson's disease
M. Werner, R. Rush, T. Kelly, S. Singh, S. Kruger,C. Olanow,A. McGarry
MOVEMENT DISORDERS (2023): S634-S634
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 657

#Citation: 68813

H-Index: 126

G-Index: 256

Sociability: 8

Diversity: 3

Activity: 22

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn